| Literature DB >> 29859750 |
Jiangying Cao1, Chunhua Ma2, Jie Zang1, Shuai Gao1, Qianwen Gao1, Xiujie Kong1, Yugang Yan1, Xuewu Liang1, Qin'ge Ding1, Chunlong Zhao1, Binghe Wang3, Wenfang Xu1, Yingjie Zhang4.
Abstract
The over-expression of aminopeptidase N on diverse malignant cells is associated with the tumor angiogenesis and metastasis. In this report, one new series of leucine ureido derivatives containing the triazole moiety was designed, synthesized and evaluated as APN inhibitors. Among them, compound 13v showed the best APN inhibition with an IC50 value of 0.089 ± 0.007 μM, which was two orders of magnitude lower than that of bestatin (IC50 = 9.4 ± 0.5 μM). Compound 13v also showed dose-dependent anti-angiogenesis activities. Even at the lower concentration (10 μM), compound 13v presented similar anti-angiogenesis activity compared with bestatin at 100 μM in both the human umbilical vein endothelial cells (HUVECs) capillary tube formation assay and the rat thoracic aorta rings test. Moreover, compared with bestatin, 13v exhibited comparable, if not better in vivo anti-metastasis activity in a mouse H22 pulmonary metastasis model.Entities:
Keywords: Aminopeptidase N; Anti-angiogenesis; Anti-metastasis; CD13; Triazole
Mesh:
Substances:
Year: 2018 PMID: 29859750 DOI: 10.1016/j.bmc.2018.04.041
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641